Ophthalmology Doctors in Clarks Summit, PA Accepting Medicare

4 Ophthalmology doctors found. Showing 1 - 4

Dr. Ajey Shashikant Alurkar, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 210 N State St Ste 1&5, Clarks Summit, PA 18411 Phone: 570-587-7500

Stanley W Boland, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 503 S State St, Clarks Summit, PA 18411 Phone: 570-587-5186    Fax: 570-586-7973

Mary Jennifer Frattali, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 503 S State St, Clarks Summit, PA 18411 Phone: 570-587-5186    Fax: 570-586-7973

Stephen Sorokanich Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 521 Northern Blvd, Clarks Summit, PA 18411 Phone: 570-586-3976    Fax: 570-585-2903

News Archive

Scientists reveal key links between childhood obesity and healthy living behaviours

Scientists from the Children's Hospital of Eastern Ontario Research Institute participated in several peer-reviewed articles that published today in the International Journal of Obesity Supplements. The series (including 16 original contributions) was prepared by the International Study of Childhood Obesity, Lifestyle and the Environment research group, a global collective of leading obesity research experts from 12 countries located on five continents.

Combining 2-DG with fenofibrate could provide non-toxic treatments for many cancers

A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.

Veterans Affairs San Diego Healthcare System initiates Pathway Fit clinical trial in obesity

Pathway Genomics Corporation, a San Diego-based genetic testing laboratory, has announced a clinical trial with the Veterans Affairs San Diego Healthcare System (VASDHS).

Positive data from Tonix's sublingual TNX-102 PK study for fibromyalgia

Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing non-addictive treatments for chronic pain syndromes, including fibromyalgia, reported positive data from an animal pharmacokinetic study of its novel sublingual formulation of TNX-102, the Company's very low dose cyclobenzaprine.

Read more Medical News

› Verified 2 days ago